Weekend therapy for the treatment of Helicobacter pylori infection
- PMID: 9625119
- DOI: 10.1111/j.1572-0241.1998.216_a.x
Weekend therapy for the treatment of Helicobacter pylori infection
Abstract
Objectives: The aim of the present study was to evaluate the efficacy and the safety of a short-term regimen (weekend therapy) in the cure of Helicobacter pylori infection and to analyze the factors that may influence the success of the treatment.
Methods: Seventy-one patients with gastric colonization by a tinidazole sensitive H. pylori strain (34 duodenal ulcer and 37 nonulcer dyspepsia) received omeprazole 40 mg o.m. for 7 days (from Monday to Sunday) and bismuth 240 mg q.i.d. + amoxicillin 1000 mg/q.i.d. + tinidazole 500 mg q.i.d. for only 2 days (Saturday and Sunday). Endoscopy, histology, culture, urease test, and susceptibility studies were done at entry and 30 days after treatment.
Results: Successful eradication was obtained in 84% of patients. The percentage of eradication was higher in duodenal ulcer patients (94%) than in those with nonulcer dyspepsia (74%; p < 0.05), and in patients who received the treatment during hot weather (94%) than in those who received the treatment during cold weather (74%; p < 0.05). Side-effects were induced by the treatment in 17% of patients, and these were all not severe, self-limiting, short-lasting, and did not require specific treatment.
Conclusions: These data suggested that weekend therapy with high doses of drugs represents an effective, safe, and inexpensive therapeutic approach for the treatment of H. pylori infection, particularly in patients with duodenal ulcer. Furthermore, they also confirm the relevant role that short-term treatments may play in the therapeutic approach to H. pylori infection, and highlight some important aspects influencing short-term schedules.
Similar articles
-
Randomized clinical trial comparing two one-week triple-therapy regimens for the eradication of Helicobacter pylori infection and duodenal ulcer healing.Am J Gastroenterol. 1998 Jan;93(1):35-8. doi: 10.1111/j.1572-0241.1998.035_c.x. Am J Gastroenterol. 1998. PMID: 9448170 Clinical Trial.
-
Impact of colloidal bismuth subnitrate in the eradication rates of Helicobacter pylori infection-associated duodenal ulcer using a short treatment regimen with omeprazole and clarithromycin: a randomized study.Am J Gastroenterol. 1995 May;90(5):718-21. Am J Gastroenterol. 1995. PMID: 7733075 Clinical Trial.
-
Azithromycin for the cure of Helicobacter pylori infection.Am J Gastroenterol. 1996 Feb;91(2):264-7. Am J Gastroenterol. 1996. PMID: 8607490
-
Triple therapy and Helicobacter pylori.Aust Fam Physician. 1996 Jan;25(1):53, 56-9. Aust Fam Physician. 1996. PMID: 8607776 Review.
-
[Helicobacter pylori and gastroduodenal pathology. Second part: Clinical aspects and therapy].Gastroenterol Clin Biol. 1991;15(5):412-20. Gastroenterol Clin Biol. 1991. PMID: 2070962 Review. French. No abstract available.
Cited by
-
Omeprazole. A review of its use in Helicobacter pylori infection, gastro-oesophageal reflux disease and peptic ulcers induced by nonsteroidal anti-inflammatory drugs.Drugs. 1998 Sep;56(3):447-86. doi: 10.2165/00003495-199856030-00012. Drugs. 1998. PMID: 9777317 Review.
-
Importance of Helicobacter pylori cagA and vacA status for the efficacy of antibiotic treatment.Gut. 2000 Mar;46(3):321-6. doi: 10.1136/gut.46.3.321. Gut. 2000. PMID: 10673291 Free PMC article. Clinical Trial.
-
Is short-term therapy really sufficient to eradicate Helicobacter pylori infection?J Zhejiang Univ Sci B. 2010 Sep;11(9):690-701. doi: 10.1631/jzus.B1000008. J Zhejiang Univ Sci B. 2010. PMID: 20803773 Free PMC article.
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical